|
Sign In to gain access to subscriptions and/or personal tools.
|
Lupus, Vol. 15, No. 12,
877-880 (2006)
DOI: 10.1177/0961203306071706
Treatment of menorrhagia associated with oral anticoagulation: efficacy and safety of the levonorgestrel releasing intrauterine device (Mirena coil)
C N Pisoni
Lupus Research Unit, The Rayne Institute, King’s College London School of Medicine at Guy’s, King’s and St Thomas’ Hospital
M J Cuadrado
Lupus Research Unit, The Rayne Institute, King’s College London School of Medicine at Guy’s, King’s and St Thomas’ Hospital
M A Khamashta
Lupus Research Unit, The Rayne Institute, King’s College London School of Medicine at Guy’s, King’s and St Thomas’ Hospital
B J Hunt
Lupus Research Unit, The Rayne Institute, King’s College London School of Medicine at Guy’s, King’s and St Thomas’ Hospital, Department of Haematology, Guy’s and St Thomas NHS Foundation Trust, London, UK, beverley.hunt{at}gstt.nhs.uk
Menorrhagia is common in women receiving oral anticoagulation. In healthy women, reductions of up to 90% of menstrual loss have been described with the levonorgestrel releasing intrauterine device (LNG-IUS). However there is no data about the use of LNG-IUS in women receiving oral anticoagulation and so we assessed the efficacy and safety of LNG-IUS in this setting. Patients with menorrhagia who used LNG-IUS and warfarin were contacted by post and asked to complete a questionnaire assessing the extent and duration of menstrual bleeding, quality of life and treatment satisfaction. The questionnaire was sent to 23 patients and returned by 17. The amount of bleeding was reduced with the LNG-IUS in 10 (58.8%) women; amenorrhea occurred in four (23.5%), no change in blood loss in one (5.9%) and greater blood loss in two (11.8%) patients. The number of sanitary pads used was less in 12 (70.6%) patients; same in one (5.9%) patient, more in two (11.8%) patients and two (11.8%) did not remember. Five patients (29.4%) had shorter duration of bleeding, four (23.5%) had amenorrhoea, four (23.5%) had longer periods and four (23.5%) had same duration by subjective assessment. Eight (47.1%) patients felt very satisfied, four (23.5%) felt satisfied, two (11.8%) felt dissatisfied with the treatment, one felt very dissatisfied (5.9%) and two (11.8%) did not respond to the question. This small study suggests LNG-IUS is effective in reducing the duration and amount of menstrual bleeding in women with menorrhagia associated with oral anticoagulation. We feel the use of LNG-IUS is a major advance in reducing menorrhagia in women on oral anticoagulation as the previous alternative-hysterectomy-is associated with an increased risk of thrombosis and bleeding
Key Words: menorrhagia • anticoagulation • mirena coil
References
- Lethaby AE, Cooke I, Rees M. Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding . Cochrane Database Syst Rev 2000; 2: CD002126.
- Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial . Contraception 1994; 49: 56-72 .[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Bergqvist A, Rybo G. Treatment of menorrhagia with intrauterine release of progesterone . Br J Obstet Gynaecol 1983; 90: 255-258 .[ISI][Medline]
[Order article via Infotrieve]
- Palareti G, Leali N, Coccheri Set al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy . Lancet 1996; 348: 423-428 .[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Ruiz-Irastorza G, Khamashta MA, Hunt BJet al. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5 . Arch Intern Med, 2002; 162: 1164-1169 .[Abstract/Free Full Text]
- Miyakis S, Lockshin MD, Atsumi Tet al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) . J Thromb Haemost 2006; 4: 295-306 .[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Royal College of Obstetricians and Gynaecologists. Initial Management of Menorhagia. (Updated Jan 2002; cited August 2006). Available from: http://www.rcog.org.uk/index.asp?PageID=698.
- Henry DA, Carless PA, O’Conell Det al. Anti-fibrinolytic use for minimizing perioperative allogenic blood transfusion . Cochcrane Database Syst Rev 2001; 1: CD001886.
- Goldenberg M, Zolti M, Hart S, Bider Det al. Endometrial resectoscopic ablation in patients with menometrorrhagia as a side effect of anticoagulant therapy . Eur J Obstet Gynecol Reprod Biol 1998; 77: 77-79 .[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Wallwiener D, Rimbach S, Kaufmann Met al. [ Hysteroscopic endometrium ablation in "high-risk" situations and in hemorrhagic diathesis] . Zentralbl Gynakol 1995; 117: 652-658 .[Medline]
[Order article via Infotrieve]
- Lahteenmaki P, Haukkamaa M, Puolakki Jet al. Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy . Br Med J 1998; 316: 1122-1126 .[Abstract/Free Full Text]
- Xiao B, Wu SC, Chong Jet al. Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia . Fertil Steril 2003; 79: 963-969 .[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Hurskainen R, Teperi J, Rissanen Pet al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up . JAMA 2004; 291: 1456-1463 .[Abstract/Free Full Text]
- Irvine GA, Campbell-Brown MB, Lumsden MAet al Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia . Br J Obstet Gynaecol 1998; 105: 592-598 .[ISI][Medline]
[Order article via Infotrieve]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
|
